Approval Rates Don’t Help
Filings and Review Times Increase FDA Approvals
By Brian Orelli
Monday, December 2, 2013
The FDA approved 35 new molecular/biological entities (NMEs/NBEs) on average in 2011-2012, substantially higher than the 20-year average of 28 approvals.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.